期刊文献+

评价核磁共振诊断宫颈癌淋巴结转移临床价值 被引量:2

Evaluation of clinical value of magnetic resonance in the diagnosis of cervical cancer with lymph node metastasis
下载PDF
导出
摘要 目的:评价核磁共振诊断宫颈癌淋巴结转移临床价值。方法:择取颈癌患者70例,患者均接受手术治疗,术前给予核磁共振检查,通过对核磁共振图像进行分析,判断临床分期及淋巴结转移情况,并以术后病理结果为金标准,对核磁共振在宫颈癌淋巴结转移诊断上的效果。结果:术前核磁共振检查分期总体符合率为90.00%(63/70),临床病变分期总体符合率为75.71%(53/70),与术后病理分期比较差异具有统计学意义(P <0.05)。在分期预测宫颈癌淋巴结转移上,核磁共振准确性为94.29%(66/70),特异性为96.55%(56/58),敏感度为83.33%(10/12)。结论:核磁共振可直观显示肿瘤淋巴结转移情况、浸润深度及肿瘤体积,术前对宫颈癌进行核磁共振检查能够有效将病变程度和范围明确,为临床分期提供参考,值得推广。 Objective To evaluate the clinical value of MRI in the diagnosis of cervical cancer with lymph node metastasis.Methods All patients underwent surgical treatment. MRI examination was performed before operation. The clinical staging and lymph node metastasis were determined by analyzing the MRI images, And postoperative pathological results as the gold standard, the effect of nuclear magnetic resonance in the diagnosis of cervical cancer lymph node metastasis. Results The overall coincidence rate of preoperative MRI examination staging was 90.00%(63/70), and the overall coincidence rate of clinical lesion staging was 75.71%(53/70), which was significantly different from postoperative pathological staging(P<0.05).In staged prediction of lymph node metastasis of cervical cancer, the accuracy of MRI was 94.29%(66/70), the specificity was96.55%(56/58), and the sensitivity was 83.33%(10/12). Conclusion MRI can visualize the lymph node metastasis, invasion depth and tumor volume of the tumor,It is worthy of promotion.
作者 杨湘雄 Yang Xiangxiong(Central Hospital of Yongzhou City(South Hospital),Yongzhou,Hunan 425006,China)
出处 《影像研究与医学应用》 2018年第23期16-17,共2页 Journal of Imaging Research and Medical Applications
关键词 核磁共振 宫颈癌 淋巴结转移 Nuclear magnetic resonance Cervical cancer Lymph node metastasis
  • 相关文献

参考文献6

二级参考文献63

  • 1Shepherd JH. Cervical cancer[ J]. Best Pract Res Clin Obstet Gynae- col,2012,26 ( 3 ) : 293 - 309.
  • 2Yeh SA,Wan Leung S, Wang CJ,et al. Postoperative radiotherapy in early stage carcinoma of the uterine cervix: treatment results and prog- nostic factors[ J]. Gynecol Oncol, 1999,72( 1 ) : 10 - 15.
  • 3Figat M, Zalewski K, Dafiska-Bidzifiska A, et al. Clinical and his- topathological factors in patients with cervical cancer allowing to iden- tify candidates for less radical surgery[ J]. Ginekol Pal ,2012,83 ( 1 ) : 16 -21.
  • 4Stegeman M,Louwen M,Van der Velden J,et al. The incidence of pa- rametrial tumor involvement in select patients with early cervix cancer is too low to justify parametrectomy [ J ]. Gynecol Oncol, 2007,105 (2) :475 -480.
  • 5Wright JD, Grigsby PW, Brooks R, et al. Utility of parametrectomy for early stage cervical cancer treated with radical hysterectomy [ J ]. Cancer,2007,110 ( 6 ) : 1281 - 1286.
  • 6Frumovitz M, Sun CC, Schmeler KM, et al. Parametrial involvement in radical hysterectomy specimens for women with early-stage cervical cancer [ J ]. Obstet Gyneco1,2009,114 ( 1 ) :93 - 99.
  • 7Schmeler KM, Frumovitz M, Ramirez PT. Conservative management of early stage cervical cancer:is there a role for less radical surgery [ J 1. Gynecol Oncol,2011,120 ( 3 ) :321 - 325.
  • 8Kodama J, Kusumoto T, Nakamura K, et al. Factors associated with parametrial involvement in stage I B1 cervical cancer and identifica- tion of patients suitable for less radical surgery [ J ]. Gynecol Oneol, 2011,122(3) :491 -494.
  • 9Selman TJ, Luesley DM, Murphy DJ, et al. Is radical hysterectomy lbr early stage cervical cancer an outdated operation [ J ]. BJOG, 2005, 112(3) :363 -365.
  • 10Driscoll DO, Halpenny D, Johnston C, et al. 18F-FDG-PET/CT is of limited value in primary staging of early stage cervical cancer[J]. Abdominal Imaging, 2015, 40(1): 127-133.

共引文献91

同被引文献6

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部